Efficacy and safety of immunochemotherapy, immunotherapy, chemotherapy, and targeted therapy as first-line treatment for advanced and metastatic esophageal cancer: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of immunochemotherapy, immunotherapy, chemotherapy, and targeted therapy as first-line treatment for advanced and metastatic esophageal cancer: a systematic review and network meta-analysis

Published:2023-09 Issue: Volume:38 Page:100841
ISSN:2666-6065
Container-title:The Lancet Regional Health - Western Pacific
language:en
Short-container-title:The Lancet Regional Health - Western Pacific

Author:

Gao Zhen^ORCID,Huang Shujie,Wang Sichao,Tang Dezhao,Xu Wei,Zeng Ruijie,Qiao Guibin^ORCID

Funder

Natural Science Foundation of Guangdong Province

Guangzhou Science and Technology Program key projects

Publisher

Elsevier BV

Subject

Infectious Diseases,Psychiatry and Mental health,Geriatrics and Gerontology,Public Health, Environmental and Occupational Health,Obstetrics and Gynecology,Health Policy,Pediatrics, Perinatology and Child Health,Internal Medicine

Reference64 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. A validated nomogram integrating hematological indicators to predict response to neoadjuvant therapy in esophageal squamous cell carcinoma patients;Wang;Ann Transl Med,2021

3. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries;Domper Arnal;World J Gastroenterol,2015

4. Esophageal cancer: risk factors, genetic association, and treatment;Huang;Asian J Surg,2018

5. Treatments for esophageal cancer: a review;Kato;Gen Thorac Cardiovasc Surg,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding the Mystery of Blood Cancer: Cause, Diagnosis, and Management;Current Cancer Therapy Reviews;2025-01

2. Tumor-produced immune regulatory factors as a therapeutic target in cancer treatment;Frontiers in Immunology;2024-08-14

3. Sex differences in survival following surgery for esophageal cancer: A systematic review and meta-analysis;Diseases of the Esophagus;2024-08-14

4. Pharmacogenomics: A Genetic Approach to Drug Development and Therapy;Pharmaceuticals;2024-07-13

5. Efficacy and safety of PD-1 Monoclonal antibodies in the treatment of esophageal squamous cell carcinoma: Systematic review and meta Regression;Heliyon;2024-07